Login / Signup

A Comparison of Individuals with Diabetes and EMPA-REG Trial Participants: Exploring Aspects of External Validity.

Alexander ChaitoffJoshua D NiforatosJingyi GongMichael A Fischer
Published in: Journal of general internal medicine (2022)
The EMPA-REG population differed from a nationally representative sample, which could affect generalizability.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • phase iii
  • study protocol
  • glycemic control
  • clinical trial
  • phase ii
  • metabolic syndrome
  • insulin resistance